Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J0463 · per 0.01 MG

Inj atropine (fresenius te)

Products billed under this code include Atropine Sulfate.

Payment limit per 0.01 MG, by effective quarter, 2Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0463

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Atropine Sulfate Henry Schein Inc. 00404-9804-20 800 $16.00
Atropine Sulfate Hikma Pharmaceuticals USA Inc. 00641-6251-10 8000 $160.00
Atropine Sulfate Accord Healthcare Inc 16729-0512-43 8000 $160.00
Atropine Sulfate HF Acquisition Co. LLC, DBA HealthFirst 51662-1619-01 800 $16.00
Atropine Sulfate HF Acquisition Co. LLC, DBA HealthFirst 51662-1619-03 8000 $160.00
Atropine Sulfate FreseniUS Kabi USA, LLC 63323-0580-20 8000 $160.00
Atropine Sulfate Somerset Pharma, LLC 70069-0481-10 8000 $160.00

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.02 +$0.003 0.01 MG Inj atropine (fresenius te) v1, posted September 17, 2026
3Q26 $0.017 +$0.003 0.01 MG Inj atropine (fresenius te) v1, posted September 15, 2026
2Q26 $0.014 – 0.01 MG Inj atropine (fresenius te) v1, posted September 15, 2026

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files